AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2021
Jan 7, 2021
31046_dirs_2021-01-07_b8e3aea8-f5da-419a-9f58-ccc492766048.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-05
Reporting Person: Almstead Neil Gregory (Chief Technical Ops Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-05 | Common Stock | S | 502 | $62.37 | Disposed | 26587 | Direct |
| 2021-01-05 | Common Stock | S | 56 | $62.37 | Disposed | 1856 | Indirect |
| 2021-01-05 | Common Stock | S | 68 | $62.37 | Disposed | 1788 | Indirect |
Footnotes
F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock.
F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs.
F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 218 RSUs from a January 3, 2018 grant of 874 RSUs.